| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.2M | -66.0% |
| R&D Expense | $54.0M | -26.7% |
| SG&A Expense | $22.1M | -1.6% |
| Operating Income | -$76.3M | +2.3% |
| Income Tax | $0 | — |
| Net Income | -$69.9M | +4.0% |
| EPS (Basic) | -$0.38 | +13.6% |
| EPS (Diluted) | -$0.38 | +13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.3M | +38.2% |
| Short-term Investments | $86.3M | -13.5% |
| Accounts Receivable | $2.4M | +35.6% |
| Current Assets | $127.3M | -3.6% |
| Total Assets | $131.7M | -8.8% |
| Current Liabilities | $15.6M | -30.5% |
| Long-term Debt | $0 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.8M | +24.5% |
| Capital Expenditures | $182K | -81.9% |
| Investing Cash Flow | $22.9M | -54.8% |
| Financing Cash Flow | $52.0M | +69.7% |
| Free Cash Flow | -$65.0M | +25.2% |
| Total Liabilities |
| $34.3M |
| -10.5% |
| Stockholders' Equity | $97.4M | -8.2% |